Medidata Solutions Inc  

(Public, NASDAQ:MDSO)   Watch this stock  
Find more results for MDSO
72.83
-1.27 (-1.71%)
Jun 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 72.60 - 74.91
52 week 28.15 - 75.22
Open 74.30
Vol / Avg. 109,728.00/171,692.00
Mkt cap 1.94B
P/E 94.55
Div/yield     -
EPS 0.77
Shares 26.59M
Beta 0.59
Inst. own 91%
Jul 29, 2013
Q2 2013 MEDIDATA SOLUTIONS INC Earnings Release Add to calendar
May 22, 2013
MEDIDATA SOLUTIONS INC at B. Riley & Co. Investor Conference
May 9, 2013
MEDIDATA SOLUTIONS INC at Jefferies Global Technology, Media and Telecom Conference
May 1, 2013
Q1 2013 MEDIDATA SOLUTIONS INC Earnings Release
Apr 30, 2013
MEDIDATA SOLUTIONS INC Annual Stockholders Meeting
Apr 29, 2013
Q1 2013 MEDIDATA SOLUTIONS INC Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 9.01% 8.25%
Operating margin 11.21% 12.77%
EBITD margin - 16.41%
Return on average assets 10.05% 8.70%
Return on average equity 15.44% 14.64%
Employees 796 -
Carbon Disclosure Rating - -

Address

8th Floor, 79 Fifth Avenue
NEW YORK, NY 10003
United States - Map
+1-212-9181800 (Phone)
+1-212-9181818 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Medidata Solutions, Inc. (Medidata) is a global provider of software-as-a-service (SaaS), clinical technology solutions. Medidata offers Medidata Rave, is a platform that integrates electronic data capture (EDC), with a clinical data management system (CDMS), in a solution that replaces traditional paper-based methods of capturing and managing clinical data. Medidata Rave offers a platform enabling sponsors to manage complex trials. Medidata customers are pharmaceutical, biotechnology and medical device companies, academic institutions, contract research organizations (CROs), and other organizations engaged in clinical trials to bring medical products and treatments to market and explore indications for existing medical products. Medidata Rave�s intuitive, user-friendly Internet-based technology facilitates rapid adoption by investigators, sponsors and CROs. On July 1, 2011, the Company acquired Clinical Force Limited (Clinical Force).

Officers and directors

Tarek A. Sherif Chairman of the Board, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Glen M. de Vries President, Director
Age: 40
Bio & Compensation  - Reuters
Cory A. Douglas Chief Financial Officer, Executive Vice President
Age: 42
Bio & Compensation  - Reuters
Steven Wilhite Executive Vice President, Chief Marketing Officer
Bio & Compensation  - Reuters
Michael I. Otner Executive Vice President, General Counsel, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Eileen M. Schloss Executive Vice President - Human Resources
Age: 59
Bio & Compensation  - Reuters
Steven I. Hirschfeld Executive Vice President - Customer Operations
Bio & Compensation  - Reuters
Bryan C. Spielman Executive Vice President - Strategy and Corporate Development
Age: 46
Bio & Compensation  - Reuters
Carlos Dominguez Independent Director
Age: 53
Bio & Compensation  - Reuters
Neil M. Kurtz M.D. Independent Director
Age: 61
Bio & Compensation  - Reuters